Skip to content

Arcolith 4000 Implantable Pacemaker Pulse-Generator

by Arco Medical Products Co.

510(k) K791165

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK791165 Date10 Jul 1979ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Arcolith 4000
510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Arcolith 4000 is an implantable pacemaker pulse-generator, designed to regulate cardiac rhythm by delivering electrical impulses to the heart. Classified as a Class III medical device under FDA regulations, it is intended for patients requiring chronic cardiac pacing to manage bradycardia or other conduction disorders.

This device is supplied sterile and intended for single-use implantation by qualified healthcare professionals in a clinical setting. It is regulated under FDA 510(k) clearance (K791165) and adheres to the specifications outlined in regulation number 870.3610. The pulse-generator is not MRI-safe and must be handled with care to ensure proper function and patient safety.

Other devices from Arco Medical Products Co.

See all devices from Arco Medical Products Co. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Arcolith 4000 pacemaker, and who should consider using it?

    The Arcolith 4000 is designed to regulate abnormal heart rhythms by delivering electrical impulses to the heart, specifically for patients with chronic bradycardia or conduction disorders. It is intended for long-term use in individuals who require consistent cardiac pacing to maintain a stable heart rate.

  • Is the Arcolith 4000 meant for reuse, or is it a single-use device?

    The Arcolith 4000 is explicitly labeled as a single-use implantable device. It is supplied sterile and intended for one-time implantation by qualified healthcare professionals in a clinical setting, ensuring patient safety and device efficacy.

  • Can this device be used in patients who require MRI scans, or are there restrictions?

    The Arcolith 4000 is explicitly noted as not MRI-safe. Patients with this device should avoid MRI procedures, as the electromagnetic fields could interfere with its function or pose safety risks.

  • How is the Arcolith 4000 regulated in the U.S., and what does that mean for clinicians?

    The Arcolith 4000 is classified as a Class III medical device under FDA regulations and has received 510(k) clearance (K791165). This means it undergoes rigorous review by the FDA’s Cardiovascular (CV) advisory committee to ensure safety and effectiveness before clinical use. Clinicians can rely on its regulatory history as evidence of compliance with U.S. standards for implantable pacemakers.

  • What storage or handling precautions should be taken with the Arcolith 4000 before implantation?

    While specific storage instructions aren’t detailed in the data, the device is supplied sterile and intended for single-use in a clinical setting. It should be handled with care to maintain sterility and integrity until implantation. Since it’s not MRI-safe, proper labeling and patient awareness are critical to prevent accidental exposure to MRI environments.